MedTrace Logo

Evaluating the Role of Cystatin C and Creatinine as Markers of Renal Recovery in Critically Ill Patients After Acute Kidney Injury.

NCT02894164 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 336

Last updated 2017-08-23

No results posted yet for this study

Summary

This is a cohort study in which patients who survive Acute Kidney Injury (AKI) during intensive care unit (ICU) admission are recalled at 3-6 months and renal function tests are performed.

The purpose of the study is describe renal function in AKI survivors at follow-up.

Additional aims are to determine how well admission values of renal function markers perform as predictors of renal function at follow-up and whether estimates of renal function at follow-up differ depending on which renal function marker is used.

Conditions

Interventions

OTHER

No intervention

Sponsors & Collaborators

Principal Investigators

  • Max Bell, PhD · Karolinska Institutet

  • Johan Mårtensson, PhD · Karolinska Institutet

  • Claes-Roland Martling, PhD · Karolinska Institutet

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-01-31
Primary Completion
2011-12-31
Completion
2014-12-31

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02894164 on ClinicalTrials.gov